Last updated: 21 July 2019 at 11:17pm EST

Elizabeth D Krell Net Worth




The estimated Net Worth of Elizabeth D Krell is at least $1.02 million dollars as of 7 May 2018. Elizabeth Krell owns over 10,000 units of Atricure Inc stock worth over $806,112 and over the last 17 years Elizabeth sold ATRC stock worth over $217,700.

Elizabeth Krell ATRC stock SEC Form 4 insiders trading

Elizabeth has made over 17 trades of the Atricure Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently Elizabeth exercised 10,000 units of ATRC stock worth $93,000 on 7 May 2018.

The largest trade Elizabeth's ever made was exercising 10,000 units of Atricure Inc stock on 7 May 2018 worth over $93,000. On average, Elizabeth trades about 4,532 units every 117 days since 2007. As of 7 May 2018 Elizabeth still owns at least 29,967 units of Atricure Inc stock.

You can see the complete history of Elizabeth Krell stock trades at the bottom of the page.



What's Elizabeth Krell's mailing address?

Elizabeth's mailing address filed with the SEC is 13005 Hawkins Cir, Hagerstown, MD 21742, USA.

Insiders trading at Atricure Inc

Over the last 19 years, insiders at Atricure Inc have traded over $52,789,242 worth of Atricure Inc stock and bought 666,621 units worth $5,937,195 . The most active insiders traders include Scott William Drake, Group I, Llc Donoghue Danie... et Management Group Viii L L C.... On average, Atricure Inc executives and independent directors trade stock every 24 days with the average trade being worth of $548,410. The most recent stock trade was executed by Maggie Yuen on 15 August 2024, trading 3,500 units of ATRC stock currently worth $84,245.



What does Atricure Inc do?

atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.



Complete history of Elizabeth Krell stock trades at Atricure Inc

Initié
Trans.
Transaction
Prix ​​total
Elizabeth D Krell
Directeur
Exercice d'option $93,000
7 May 2018
Elizabeth D Krell
Directeur
Exercice d'option $141,700
12 Mar 2018
Elizabeth D Krell
Directeur
Exercice d'option $80,400
21 Aug 2017
Elizabeth D Krell
Directeur
Exercice d'option $101,000
16 May 2017
Elizabeth D Krell
Directeur
Exercice d'option $95,000
14 Nov 2016
Elizabeth D Krell
Directeur
Exercice d'option $51,500
12 Sep 2016
Elizabeth D Krell
Directeur
Exercice d'option $20,640
16 Aug 2016
Elizabeth D Krell
Directeur
Exercice d'option $79,900
7 Mar 2016
Elizabeth D Krell
Directeur
Exercice d'option $79,900
7 Mar 2016
Elizabeth D Krell
Directeur
Exercice d'option $79,900
1 Dec 2015
Elizabeth D Krell
Directeur
Exercice d'option $79,900
10 Nov 2015
Elizabeth D Krell
Directeur
Vente $217,700
14 May 2015
Elizabeth D Krell
Directeur
Exercice d'option $79,900
11 May 2015
Elizabeth D Krell
Directeur
Exercice d'option $79,900
26 Feb 2015
Elizabeth D Krell
Directeur
Exercice d'option $2,580
7 Mar 2012
Elizabeth D Krell
Directeur
Exercice d'option $2,580
15 Jun 2011
Elizabeth D Krell
Directeur
Acheter $5,350
10 Jun 2008


Atricure Inc executives and stock owners

Atricure Inc executives and other stock owners filed with the SEC include: